Back to top

View the PFP Archive

ZACKS
Foot in Mouth Disease?

Stocks sold off 1% early on Wednesday. Just as I was starting to feel foolish for saying yesterday that Washington "Does Not Matter!", stocks started to rise nearly erasing all the early losses by the close.

The most interesting news on the day was the slightly lower than expected ADP Employment report which included negative revisions to previous months. I am not going to pretend this is good news. However, I find it to be nothing more than statistical noise. Meaning a touch under expectations, but not anything that says the improvements in employment have reversed course.

We are still in a Muddle Through Economy. Never too hot. Never too cold. And the new readings on ADP employment are right in line with that Muddle Through course which has produced a 154% return for the S&P since March 2009. Not too shabby.

However, this bull rally is becoming mature. Stocks are easily at fair value. Some might even say a notch beyond that.

Until there is a recession in the offing, then no reason to fear losses ahead. More likely 2014 is shaping up to be a sideways year for the overall market. That means about half the stocks will be up and the other half down.

So the path to outperformance is about putting the odds in your favor to own more of the 50% that go higher. And to look at opportunities beyond our borders. And to consider ETFs that tap into the profitable industries and niches. And, and, and...

That is a lot to think about if you are only investing part time. That is why you rely upon experts like Zacks to show you the way. And we have the perfect service to show you all the approaches that are likely to produce market topping results.

It's called Zacks Confidential. Since launching in August 2012 it has already become our most popular service...likely because it is also our least expensive at only $5 per month.

If you don't want to spend $5 a month, then it's high-time to look in the mirror and ask how serious you are about making your financial goals a reality.

For the rest of you, it's time you learn more about Zacks Confidential.

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Please login to Zacks.com or register to post a comment.

Sponsor

All Zacks' Private Buys & Sells: $1

No other investment research firm offers anything like this. See all of our real-time buys, sells, and market insights.

One month. One dollar. Not one cent of further obligation.

Our best short-term trades, long-term investments and market insights can bolster your portfolio no matter what the market is doing. Click below to see why we can give them all to you for just $1. Please note that your chance to take part in this special arrangement may end at any time.

Get all our timely Buy & Sells today!

Bull & Bear of the Day

Zacks Rank #1

WageWorks (WAGE)

Here's a way Obamacare could benefit your portfolio.

 

Zacks Rank #5

Genomic Health (GHDX)

This pioneer in specialized cancer diagnostics has no near-term catalysts to drive earnings or shares.


Stock Picking Strategies

Earnings Acceleration for Future Outperformers  ››

Bull Market Breadth & Froth  ››

3 Secret Social Media Stocks  ››


Funds Commentary

3 Dirt Cheap Mutual Funds to Buy Now  ››

Inside the New iShares Ultra Short Term Bond ETF  ››

3 Biggest ETF Winners from the 3rd Quarter  ››


Options Strategies

How to Determine Correct Position Size  ››


Video Reports

3 ETFs to Watch as the Government Shutdown Drags On

These ETFs could be in for some rocky trading thanks to the shutdown.

This Weeks Growth & Income Stocks: (ALV) (SJM)

Growth & Income Stock Strategist, Todd Bunton, highlights Autoliv (ALV) and Smuckers (SJM) on October 2, 2013.

Stocks Take Their Cue From Washington

Zacks strategists weigh in on how the market might react to possible shut down scenarios and debt ceiling talks.

Earnings HQ

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

See All »

Sponsor

Start Every Day Ahead of Wall Street

Before you make a trade, get today's market news from Zacks' latest Ahead of Wall Street article. With timely information from Zacks analysts, each daily article features a preview of where the market is headed. Plus, Bull and Bear stocks of the day, Zacks #1s on the move, stock research reports, earnings and economic news, and a top-headline analyst blog. All of it in one easy-to-follow place to give you the edge.

Get the latest news>>


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606